What is the recommended tapering schedule for discontinuing citalopram (Celexa) from 20 mg using 5 mg increments?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Citalopram Tapering Schedule for Discontinuation

The recommended tapering schedule for discontinuing citalopram 20 mg is a gradual reduction of 5 mg every 2-4 weeks to minimize withdrawal symptoms. 1, 2

Understanding Citalopram Discontinuation Syndrome

Abrupt discontinuation of citalopram can lead to significant withdrawal symptoms due to its relatively short half-life compared to other SSRIs like fluoxetine. These symptoms may include:

  • Dizziness, light-headedness, vertigo, and sensory disturbances 3, 4
  • Nausea, vomiting, and gastrointestinal distress 3
  • Fatigue, lethargy, myalgia, and flu-like symptoms 3, 2
  • Anxiety, irritability, agitation, and mood disturbances 3, 4
  • Confusion, trouble concentrating, and cognitive effects 4
  • Sleep disturbances and insomnia 2

Recommended Tapering Schedule

For a patient on citalopram 20 mg using 5 mg increments:

  1. First reduction: Decrease from 20 mg to 15 mg daily and maintain for 2-4 weeks 1, 2
  2. Second reduction: Decrease from 15 mg to 10 mg daily and maintain for 2-4 weeks 1, 2
  3. Third reduction: Decrease from 10 mg to 5 mg daily and maintain for 2-4 weeks 1, 2
  4. Final step: Discontinue completely after 2-4 weeks at 5 mg 1, 2

Important Considerations

  • Extended taper may be necessary: For patients experiencing significant withdrawal symptoms, consider extending the taper duration at each dose level or implementing smaller incremental decreases 5, 2
  • Monitor for relapse: Be aware that discontinuation symptoms can be mistaken for relapse of depression 3, 6
  • Symptom management: If withdrawal symptoms become severe, return to the previous dose and resume tapering at a slower rate 2
  • Risk factors: Higher doses and plasma concentrations of citalopram are associated with greater risk of discontinuation syndrome 4

Special Situations

  • Patients with anxiety disorders: May require even more gradual tapering as they can be more sensitive to discontinuation effects 1
  • Long-term users: Patients who have been on citalopram for years may benefit from an even more gradual taper, potentially extending over several months 5
  • Concurrent medications: If the patient is also taking benzodiazepines, taper the citalopram first as benzodiazepine withdrawal can be more dangerous 1

Follow-up Recommendations

  • Schedule follow-up appointments at each dose reduction stage to monitor for withdrawal symptoms 2
  • Educate patients that some symptoms may persist for weeks to months after complete discontinuation 2
  • Consider providing symptomatic relief for specific withdrawal symptoms as needed 2

Remember that research has shown that patients who discontinue antidepressants have a higher risk of relapse within 52 weeks compared to those who maintain therapy, so careful monitoring for depression recurrence is essential 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Discontinuing antidepressants: Pearls and pitfalls.

Cleveland Clinic journal of medicine, 2022

Research

Clinical management of antidepressant discontinuation.

The Journal of clinical psychiatry, 1997

Research

Maintenance or Discontinuation of Antidepressants in Primary Care.

The New England journal of medicine, 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.